ALB |
Albumin |
ALD |
Alcoholic liver disease |
ALF |
Alcoholic liver fibrosis |
ALT |
Alanine aminotransferase |
ALP |
Alkaline phosphatase |
AST |
Aspartate aminotransferase |
α-SMA |
alpha-Smooth muscle acti |
BA |
Bile acid |
Bax |
Bcl-2-associated x protein |
BCL-2 |
B-cell lymphoma 2 |
BDL |
Bile duct ligation |
CCl4
|
Carbon tetrachloride |
Col |
Collagen type |
CTP |
Child-Turcotte-Pugh |
EtOH |
Ethyl alcohol |
GGT |
gamma Glutamyl peptidase |
GSH |
Glutathione |
HCC |
Hepatocellular carcinoma |
HE |
Hepatic encephalopathy |
HSP |
Heat shock proteins |
IL |
Interleukin |
iNOS |
Inducible nitric oxide synthase |
MAPK |
Mitogen-activated protein kinase |
MDA |
Malondialdehyde |
MHE |
Minimal hepatic encephalopathy |
MELD |
Model for end-stage liver disease |
Mmp |
Matrix metallopeptidases |
NF-κB |
Nuclear factor kappa-light-chain-enhancer of activated b cells |
SIRT |
Selective internal radiation therapy |
SCFAs |
Short chain fatty acids |
SOD |
Superoxide dismutase |
TAA |
Thioacetamide |
TEER |
Transepithelial electrical resistance |
TG |
Triglycerides |
TBIL |
Total bilirubin |
Timp |
Tissue inhibitor of metallopeptidase |
TLR |
Toll-like receptor |
TNF-α |
Tumor necrosis factor alpha |
Zo-1 |
Zonula occludenes-1 |